The India cardiovascular market is projected to grow from $1.00 Bn in 2022 to $1.79 Bn in 2030 with a CAGR of 7.52% for the year 2022-2030. Increased incidence of cardiovascular diseases and improvements in diagnosis and treatment options in India are the major drivers for the growth of the market.
The India home healthcare market is expected to witness growth from $6.59 Bn in 2022 to $15.12 Bn in 2030 with a CAGR of 10.93% for the year 2022-2030. Advancing technologies and the rising prevalence of lifestyle diseases in India are major market drivers. Some of the key players in the market include Portea and Apollo Homecare.
The rising awareness about menopausal symptoms and their consequences on the health of Indian women is driving the growth of the India menopause treatment market during the forecast period. Hormone therapy, Gabapentin, and Clonidine are major treatment options for menopause in India.
The India multiple myeloma market is projected to grow as a result of the increasing prevalence of hematological cancers in India. The market is segmented by disease type, treatment type, diagnosis, dosage form, route of administration, end users and by distribution channel.
The India physiotherapy market is projected to grow from $967 Mn in 2022 to $1,907 Mn in 2030 with a CAGR of 8.85% for the year 2022-2030. The market is segmented by treatment, application and by practice type. Some of the key players in the India physiotherapy market are BTL Industries and Djo Global India Healthcare.
India is one of the fastest-growing dental markets in the world. The India dental care market is projected to grow from $653 Mn in 2022 to $1,339 Mn in 2030 with a CAGR of 9.4% for the year 2022-2030. The market is segmented by product, treatment, and by end users.
Rising inclination of Indian consumers towards dietary supplements is projected to augment the growth of India vitamins and minerals market from $494 Mn in 2022 to $1,017 Mn in 2030 with a CAGR of 9.45% for the year 2022-2030. The market is segmented by ingredients, dosage form, functionality, and by end user.
India gastrointestinal drugs market is projected to grow as digestive problems are more common in Indian households. Major gastrointestinal disorders in India include gastroenteritis, celiac disease, and Crohn's disease. The market is segmented by drug type and by route of administration.
Osteoarthritis is the most prevalent joint disease with 22% to 39% prevalence in India. The India osteoarthritis drugs market is projected to grow as osteoarthritis continues to be the most prevalent disorder affecting the elderly population in India. Zydus Cadila and Sun Pharma are some of the key players in the market.
The India dermatological therapeutics market is projected to grow from $632 Mn in 2022 to $1,504 Mn in 2030 with a CAGR of 11.44% for the forecast period 2022-2030. Major dermatological disorders include eczema, tinea pedis, and angioedema. Corticosteroids and retinoids are some of the common drugs used for the treatment of dermatological conditions.
The growing burden of diabetic retinopathies and glaucoma in the Indian population and the increase in demand for technological advancements for the treatment of eye disorders are responsible for the growth of the India ophthalmology therapeutics market. The market is segmented by drug class and by dosage form.
The concept of anti-aging is gaining momentum in the market as the effects of aging such as skin elasticity loss and collagen loss are observed in the Indian population. As a result of this, the India anti-aging drugs market is expected to grow during the forecast period. The market is segmented by type and by treatment.